Healthcare & Life Sciences
Osmol Therapeutics
United Statesosmoltherapeutics.com
Osmol Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
Activeseed
seed
Stage
1
Investors
About Osmol Therapeutics
Based in the United States, Osmol Therapeutics is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Osmol Therapeutics is developing OSM-0205, a drug candidate designed to prevent chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced cognitive impairment (CICI) in patients undergoing taxane-based chemotherapy.
Explore Osmol Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.